Search results
Should You Buy This Stock After a Regulatory Setback?
The Motley Fool via AOL· 2 hours agoThe past two-and-a-half years have been rough for Moderna (NASDAQ: MRNA). Though the biotech was...
Moderna and Pfizer In Talks With U.S. To Make a Bird Flu Vaccine
Barrons.com· 4 days agoFEATURE Moderna and Pfizer are in talks with the federal government over a potential avian flu...
Is Moderna, Inc. (NASDAQ:MRNA) Trading At A 43% Discount?
Simply Wall St. via Yahoo Finance· 23 hours agoKey Insights The projected fair value for Moderna is US$294 based on 2 Stage Free Cash Flow to...
Moderna Announces Data to be Presented at 2024 ASCO Annual Meeting
Digital Journal· 4 days agoPRESS RELEASE Published May 22, 2024 ACCESSWIRE Moderna to host an investor event via webcast on Monday, June 3 at 6:15 PM CDT CAMBRIDGE, MA / ACCESSWIRE / May 22, 2024 / ...
Moderna Has Big AI News. Is the Stock a Buy?
The Motley Fool via AOL· 4 days agoModerna (NASDAQ: MRNA) isn't new to artificial intelligence (AI). The biotech best known for its billion-dollar coronavirus vaccine has been using this...
Cancer Biotech Stocks Are on the Move Ahead of a Big Event. What to Know.
Barrons.com· 2 days agoThe American Society of Clinical Oncology is set to gather on May 31 in Chicago for its annual...
Why Vaccine Stocks Rallied This Week
Motley Fool via Yahoo Finance· 2 days agoShares of vaccine stocks Moderna (NASDAQ: MRNA), Novavax (NASDAQ: NVAX), and BioNTech SE (NASDAQ: BNTX) rallied this week, appreciating 23.4%, 16.4%, and...
Moderna, CureVac, other vaccine stocks jump as new human bird-flu cases reported in U.S., Australia
Market Watch· 4 days agoVaccine-related stocks moved sharply higher Wednesday as new human bird-flu cases were reported in...
Moderna director Afeyan sells over $2.3 million in company stock By Investing.com
Investing.com· 2 days agoModerna , Inc. (NASDAQ:MRNA) director Noubar Afeyan has sold a portion of his holdings in the...
Heard on the Street: Moderna Got a Boost From Bird Flu, but Don’t Count Your Chicks
The Wall Street Journal· 3 days agoModerna, BioNTech, CureVac and Novavax have added billions of dollars in combined market...